Fetal Microchimerism and Cancer
- 1 December 2008
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 68 (23) , 9567-9569
Abstract
The persistence of fetal stem cells with multilineage potential in women who have been pregnant, a phenomenon known as fetal microchimerism, is emerging as a potential contributing factor in certain diseases, including cancer. For example, fetal microchimerism has been implicated in autoimmune disease, wound healing, and cancer. Studies of this phenomenon may provide a novel perspective on cancer in women, including in breast, ovarian, and lung cancers. [Cancer Res 2008;68(23):9567–9]Keywords
This publication has 15 references indexed in Scilit:
- Fetal-maternal microchimerism in normal parous females and parous female cancer patientsExperimental Hematology, 2008
- Decreased Bladder Cancer Growth in Parous MiceUrology, 2008
- Case-Control Study of Fetal Microchimerism and Breast CancerPLOS ONE, 2008
- Beneficial effects of fetal–maternal microchimerism on the activated haplo-identical peripheral blood stem cell treatment for cancerCytotherapy, 2008
- Fetal Microchimerism in Women with Breast CancerCancer Research, 2007
- Normal Stem Cells and Cancer Stem Cells: The Niche MattersCancer Research, 2006
- Transfer of Fetal Cells With Multilineage Potential to Maternal TissueJAMA, 2004
- Cervical cancer and microchimerismObstetrics & Gynecology, 2003
- Male microchimerism in healthy women and women with scleroderma: cells or circulating DNA? A quantitative answerBlood, 2002
- Pregnancy and microchimerism in autoimmune disease: Protector or insurgent?Arthritis & Rheumatism, 2002